Paul Tudor Jones's CME Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 60.0K shares of CME Group Inc. (CME) worth $16.21 M, representing 0.03% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in CME, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2013, adding 330.1K shares. Largest reduction occurred in Q1 2014, reducing 335.4K shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's CME Group (CME) Holding Value Over Time
Track share changes against reported price movement
Quarterly CME Group (CME) Trades by Paul Tudor Jones
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +56,533 | Add 0.00% | 56,532 | $75.96 |
| Q3 2013 | -19,400 | Reduce 34.32% | 37,132 | $73.87 |
| Q4 2013 | +330,066 | Add 888.90% | 367,198 | $78.46 |
| Q1 2014 | -335,398 | Reduce 91.34% | 31,800 | $74.03 |
| Q2 2014 | +1,100 | Add 3.46% | 32,900 | $70.94 |
| Q3 2014 | -2,900 | Reduce 8.81% | 30,000 | $79.97 |
| Q4 2014 | +6,001 | Add 20.00% | 36,001 | $88.64 |
| Q1 2015 | -1,101 | Reduce 3.06% | 34,900 | $94.70 |
| Q2 2015 | +94,200 | Add 269.91% | 129,100 | $93.06 |
| Q3 2015 | -65,328 | Reduce 50.60% | 63,772 | $92.74 |
| Q4 2015 | -21,307 | Reduce 33.41% | 42,465 | $90.59 |
| Q1 2016 | -4,495 | Reduce 10.59% | 37,970 | $96.05 |
| Q2 2016 | +82,071 | Add 216.15% | 120,041 | $97.40 |
| Q3 2016 | -71,248 | Reduce 59.35% | 48,793 | $104.52 |
| Q4 2016 | -1,193 | Reduce 2.45% | 47,600 | $115.36 |
| Q1 2017 | +8,119 | Add 17.06% | 55,719 | $118.79 |
| Q2 2017 | -5,898 | Reduce 10.59% | 49,821 | $125.25 |
| Q3 2017 | +18,838 | Add 37.81% | 68,659 | $135.69 |
| Q4 2017 | -2,729 | Reduce 3.97% | 65,930 | $146.05 |
| Q1 2018 | -5,211 | Reduce 7.90% | 60,719 | $161.75 |
| Q2 2018 | -654 | Reduce 1.08% | 60,065 | $163.92 |
| Q1 2019 | +11,187 | Add 18.62% | 71,252 | $164.58 |
| Q2 2019 | -11,187 | Reduce 15.70% | 60,065 | $194.11 |
| Q4 2019 | -54 | Reduce 0.09% | 60,011 | $200.71 |
| Q1 2020 | -11 | Reduce 0.02% | 60,000 | $172.92 |
| Q2 2020 | +6,378 | Add 10.63% | 66,378 | $162.54 |
| Q3 2020 | -5,794 | Reduce 8.73% | 60,584 | $167.30 |
| Q4 2020 | -562 | Reduce 0.93% | 60,022 | $182.05 |
| Q1 2021 | -22 | Reduce 0.04% | 60,000 | $204.23 |
| Q2 2021 | +7,140 | Add 11.90% | 67,140 | $212.68 |
| Q3 2021 | +1,799 | Add 2.68% | 68,939 | $193.37 |
| Q4 2021 | -6,903 | Reduce 10.01% | 62,036 | $228.46 |
| Q1 2022 | +7,292 | Add 11.75% | 69,328 | $237.85 |
| Q2 2022 | -9,106 | Reduce 13.13% | 60,222 | $204.69 |
| Q3 2022 | +66,770 | Add 110.87% | 126,992 | $177.13 |
| Q4 2022 | +16,223 | Add 12.77% | 143,215 | $0.17 |
| Q1 2023 | -25,854 | Reduce 18.05% | 117,361 | $0.19 |
| Q2 2023 | -5,809 | Reduce 4.95% | 111,552 | $185.29 |
| Q3 2023 | -51,551 | Reduce 46.21% | 60,001 | $200.22 |
| Q4 2023 | -1 | Reduce 0.00% | 60,000 | $210.60 |
| Q1 2024 | +186 | Add 0.31% | 60,186 | $215.29 |
| Q2 2024 | -186 | Reduce 0.31% | 60,000 | $196.60 |
| Q3 2024 | +55 | Add 0.09% | 60,055 | $220.65 |
| Q4 2024 | -55 | Reduce 0.09% | 60,000 | $232.23 |
| Q2 2025 | +47,187 | Add 78.64% | 107,187 | $275.62 |
| Q3 2025 | -47,187 | Reduce 44.02% | 60,000 | $270.19 |
Paul Tudor Jones's CME Group Investment FAQs
Paul Tudor Jones first purchased CME Group Inc. (CME) in Q2 2013, acquiring 56,532 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held CME Group Inc. (CME) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's largest addition to CME Group Inc. (CME) was in Q4 2013, adding 367,198 shares worth $28.81 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 60,000 shares of CME Group Inc. (CME), valued at approximately $16.21 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, CME Group Inc. (CME) represents approximately 0.03% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's peak holding in CME Group Inc. (CME) was 367,198 shares, as reported at the end of Q4 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.